He Cao

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Small cell lung cancer (SCLC) relapses rapidly after the initial response to chemotherapy and shows drug-resistance. This study was to investigate the efficacy and safety of cellular immunotherapy (CIT) with autologous natural killer (NK), γδT, and cytokine-induced killer (CIK) cells as maintenance therapy for SCLC patients. A pilot prospective cohort study(More)
  • 1